Restoring the gut microbiome for the treatment of inflammatory bowel diseases

World Journal of Gastroenterology

Volumn 20, Issue 13, 2014, Pages 3468-3474

  Allegretti, Jessica R ^a   Hamilton, Matthew J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Clostridium difficile; Crohn's; Dysbiosis; Fecal transplantation; Microbiota; Pouchitis; Probiotic; Ulcerative colitis

Indexed keywords

ENEMA; PROBIOTIC AGENT;

ABDOMINAL CRAMP; ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COLONOSCOPY; CROHN DISEASE; ERUCTATION; FECAL MICROBIOTA TRANSPLANTATION; FECES ANALYSIS; FOLLOW UP; HUMAN; ILEITIS; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; NAUSEA; PATHOGENESIS; POLYMERASE CHAIN REACTION; SCREENING; SYSTEMATIC REVIEW (TOPIC); TRANSPLANTATION; ULCERATIVE COLITIS; BIOLOGICAL THERAPY; CLOSTRIDIUM INFECTION; DYSBIOSIS; FECES; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MICROFLORA; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; TREATMENT OUTCOME;

BIOLOGICAL THERAPY; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; CROHN DISEASE; DYSBIOSIS; FECES; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINES; MICROBIOTA; POUCHITIS; TREATMENT OUTCOME;

EID: 84897508923     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i13.3468     Document Type: Article

References (53)

1. Carter MJ, Lobo AJ, Travis SP. Guidelines for the management of inflammatory bowel disease in adults. Gut 2004; 53 Suppl 5: V1-16 [PMID: 15306569 DOI: 10.1136/ gut.2004.043372]
2. Garrett WS, Gordon JI, Glimcher LH. Homeostasis and inflammation in the intestine. Cell 2010; 140: 859-870 [PMID: 20303876 DOI: 10.1016/j.cell.2010.01.023]
3. Spehlmann ME, Begun AZ, Burghardt J, Lepage P, Raedler A, Schreiber S. Epidemiology of inflammatory bowel disease in a German twin cohort: results of a nationwide study. Inflamm Bowel Dis 2008; 14: 968-976 [PMID: 18253950 DOI: 10.1002/ibd.20380]
4. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90: 859-904 [PMID: 20664075 DOI: 10.1152/physrev.00045.2009]
5. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC, Finlay BB. Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae. Cell Host Microbe 2007; 2: 204 [PMID: 18030708]
6. Peterson DA, Frank DN, Pace NR, Gordon JI. Metagenomic approaches for defining the pathogenesis of inflammatory bowel diseases. Cell Host Microbe 2008; 3: 417-427 [PMID: 18541218 DOI: 10.1016/j.chom.2008.05.001]
7. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Järnerot G, Tysk C, Jansson JK, Engstrand L. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 2010; 139: 1844-1854.e1 [PMID: 20816835 DOI: 10.1053/j.gastro.2010.08.049]
8. Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases. Curr Opin Infect Dis 2009; 22: 292-301 [PMID: 19352175 DOI: 10.1097/ QCO.0b013e32832a8a5d]
9. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-594 [PMID: 18242222 DOI: 10.1053/j.gastro.2007.11.059]
10. Borody TJ, Paramsothy S, Agrawal G. Fecal microbiota transplantation: indications, methods, evidence, and future directions. Curr Gastroenterol Rep 2013; 15: 337 [PMID: 23852569 DOI: 10.1007/s11894-013-0337-1]
11. Kassam Z, Lee CH, Yuan Y, Hunt RH. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013; 108: 500-508 [PMID: 23511459 DOI: 10.1038/ajg.2013.59]
12. Mattila E, Uusitalo-Seppälä R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M, Moilanen V, Salminen K, Seppälä M, Mattila PS, Anttila VJ, Arkkila P. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490-496 [PMID: 22155369 DOI: 10.1053/j.gastro.2011.11.037]
13. Rohlke F, Surawicz CM, Stollman N. Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 2010; 44: 567-570 [PMID: 20485184 DOI: 10.1097/MCG.0b013e3181dadb10]
14. Mellow MH, Kanatzar A. Colonoscopic fecal bacteriotherapy in the treatment of recurrent Clostridium difficile infection--results and follow-up. J Okla State Med Assoc 2011; 104: 89-91 [PMID: 21608450]
15. Garborg K, Waagsbø B, Stallemo A, Matre J, Sundøy A. Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 2010; 42: 857-861 [PMID: 20662620 DOI: 10.3109/00365548.2010.499541]
16. MacConnachie AA, Fox R, Kennedy DR, Seaton RA. Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM 2009; 102: 781-784 [PMID: 19726581 DOI: 10.1093/qjmed/hcp118]
17. Lund-Tønnesen S, Berstad A, Schreiner A, Midtvedt T. [Clostridium difficile-associated diarrhea treated with homologous feces]. Tidsskr Nor Laegeforen 1998; 118: 1027-1030 [PMID: 9531822]
18. Kelly CR, de Leon L, Jasutkar N. Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46: 145-149 [PMID: 22157239 DOI: 10.1097/ MCG.0b013e318234570b]
19. Polák P, Freibergerová M, Juránková J, Kocourková H, Mikesová L, Svačina R, Husa P. [First experiences with faecal bacteriotherapy in the treatment of relapsing pseudomembranous colitis due to Clostridium difficile]. Klin Mikrobiol Infekc Lek 2011; 17: 214-217 [PMID: 22247032]
20. Yoon SS, Brandt LJ. Treatment of refractory/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol 2010; 44: 562-566 [PMID: 20463588 DOI: 10.1097/ MCG.0b013e3181dac035]
21. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580-585 [PMID: 12594638 DOI: 10.1086/367657]
22. Kassam Z, Hundal R, Marshall JK, Lee CH. Fecal transplant via retention enema for refractory or recurrent Clostridium difficile infection. Arch Intern Med 2012; 172: 191-193 [PMID: 22271132 DOI: 10.1001/archinte.172.2.191]
23. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989; 1: 164 [PMID: 2563083]
24. Borody TJ, George L, Andrews P, Brandl S, Noonan S, Cole P, Hyland L, Morgan A, Maysey J, Moore-Jones D. Bowelflora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989; 150: 604 [PMID: 2783214]
25. Borody TJ, Warren EF, Leis SM, Surace R, Ashman O, Siarakas S. Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 2004; 38: 475-483 [PMID: 15220681]
26. Borody TJ, Warren EF, Leis S, Surace R, Ashman O. Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003; 37: 42-47 [PMID: 12811208]
27. Anderson JL, Edney RJ, Whelan K. Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease. Aliment Pharmacol Ther 2012; 36: 503-516 [PMID: 22827693 DOI: 10.1111/j.1365-2036.2012.05220.x]
28. Borody TJ, Campbell J. Fecal microbiota transplantation: techniques, applications, and issues. Gastroenterol Clin North Am 2012; 41: 781-803 [PMID: 23101687 DOI: 10.1016/ j.gtc.2012.08.008]
29. Angelberger S, Reinisch W, Makristathis A, Lichtenberger C, Dejaco C, Papay P, Novacek G, Trauner M, Loy A, Berry D. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013; 108: 1620-1630 [PMID: 24060759 DOI: 10.1038/ajg.2013.257]
30. Brandt LJ, Aroniadis OC. An overview of fecal microbiota transplantation: techniques, indications, and outcomes. Gastrointest Endosc 2013; 78: 240-249 [PMID: 23642791 DOI: 10.1016/j.gie.2013.03.1329]
31. van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, Visser CE, Kuijper EJ, Bartelsman JF, Tijssen JG, Speelman P, Dijkgraaf MG, Keller JJ. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; 368: 407-415 [PMID: 23323867 DOI: 10.1056/NEJMoa1205037]
32. Sinh P, Barrett TA, Yun L. Clostridium difficile Infection and Inflammatory Bowel Disease: A Review. Gastroenterol Res Pract 2011; 2011: 136064 [PMID: 21915178 DOI: 10.1155/2011/136064]
33. Reddy SS, Brandt LJ. Clostridium difficile infection and inflammatory bowel disease. J Clin Gastroenterol 2013; 47: 666-671 [PMID: 23507767 DOI: 10.1097/ MCG.0b013e31828b288a]
34. Pardi DS, Sandborn WJ. Systematic review: the management of pouchitis. Aliment Pharmacol Ther 2006; 23: 1087-1096 [PMID: 16611268 DOI: 10.1111/j.1365-2036.2006.02884.x]
35. Lovegrove RE, Tilney HS, Heriot AG, von Roon AC, Athanasiou T, Church J, Fazio VW, Tekkis PP. A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum 2006; 49: 1293-1306 [PMID: 16830218 DOI: 10.1007/s10350-006-0608-0]
36. Kartheuser A, Stangherlin P, Brandt D, Remue C, Sempoux C. Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. Fam Cancer 2006; 5: 241-260; discussion 261-262 [PMID: 16998670 DOI: 10.1007/s10689-005-5672-4]
37. Shen B. Pouchitis: what every gastroenterologist needs to know. Clin Gastroenterol Hepatol 2013; 11: 1538-1549 [PMID: 23602818 DOI: 10.1016/j.cgh.2013.03.033]
38. Gionchetti P, Rizzello F, Poggioli G, Morselli C, Lammers KM, Campieri M. Probiotic therapy to prevent pouchitis onset. Dis Colon Rectum 2005; 48: 1493; author reply 1493-1494 [PMID: 15793632 DOI: 10.1007/s10350-004-0952-x]
39. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, Bazzocchi G, Poggioli G, Miglioli M, Campieri M. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-309 [PMID: 10930365]
40. Turina M, Pennington CJ, Kimberling J, Stromberg AJ, Petras RE, Galandiuk S. Chronic pouchitis after ileal pouchanal anastomosis for ulcerative colitis: effect on quality of life. J Gastrointest Surg 2006; 10: 600-606 [PMID: 16627228 DOI: 10.1016/j.gassur.2005.08.013]
41. Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354-360 [PMID: 20048681 DOI: 10.1097/MCG.0b013e3181c87e02]
42. Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A. Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761-767 [PMID: 22290405 DOI: 10.1038/ajg.2011.482]
43. Kennedy RJ, Hoper M, Deodhar K, Erwin PJ, Kirk SJ, Gardiner KR. Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br J Surg 2000; 87: 1346-1351 [PMID: 11044159 DOI: 10.1046/ j.1365-2168.2000.01615.x]
44. Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 2012; 72: 803-823 [PMID: 22512365 DOI: 10.2165/11632710-000000 000-00000]
45. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003; 22: 56-63 [PMID: 12569115]
46. Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, Otsuka M, Hasunuma O, Kurihara R, Iwasaki A, Arakawa Y. Randomized placebo-controlled trial assessing the effect of bifidobacteria-fermented milk on active ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 1133-1141 [PMID: 15569116 DOI: 10.1111/j.1365-2036.2004.02268.x]
47. De Leon LM, Watson JB, Kelly CR. Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection. Clin Gastroenterol Hepatol 2013; 11: 1036-1038 [PMID: 23669309 DOI: 10.1016/ j.cgh.2013.04.045]
48. Schwartz M, Gluck M, Koon S. Norovirus gastroenteritis after fecal microbiota transplantation for treatment of Clostridium difficile infection despite asymptomatic donors and lack of sick contacts. Am J Gastroenterol 2013; 108: 1367 [PMID: 23912408 DOI: 10.1038/ajg.2013.164]
49. Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 2011; 472: 57-63 [PMID: 21475195 DOI: 10.1038/nature09922]
50. Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, Pettersson S. Host-gut microbiota metabolic interac tions. Science 2012; 336: 1262-1267 [PMID: 22674330 DOI: 10.1126/science.1223813]
51. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-1031 [PMID: 17183312 DOI: 10.1038/nature05414]
52. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK, Hammer RE, Williams SC, Crowley J, Yanagisawa M, Gordon JI. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008; 105: 16767-16772 [PMID: 18931303 DOI: 10.1073/ pnas.0808567105]
53. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328: 228-231 [PMID: 20203013 DOI: 10.1126/science.1179721]